- 期刊
- OpenAccess
Intrathecal 0.75% Isobaric Ropivacaine Versus 0.5% Heavy Bupivacaine for Elective Cesarean Delivery: A Randomized Controlled Trial
並列摘要
OBJECTIVE: Ropivacaine, a local anesthetic with duration of action of 2-3 hours, has shown greater selectivity for sensory blockade along with lower systemic toxicity as compared to bupivacaine when used for spinal anesthesia. This study was aimed to compare the intrathecal efficacy and safety of 0.75% isobaric ropivacaine for cesarean delivery with 0.5% heavy bupivacaine in parturients. MATERIALS AND METHODS: We enrolled 46 parturients of ASA (American Society of Anesthesiologists) grade I-II scheduled for elective cesarean delivery under spinal anesthesia for this prospective randomized control trial. The patients were randomized to receive either 12.5 mg of 0.5% hyperbaric bupivacaine or 24 mg of 0.75% isobaric ropivacaine intrathecally. Intraoperative hemodynamic parameters, characteristics of sensory and motor nerve block, neonatal outcome and maternal adverse effect (such as hypotension, bradycardia, nausea, vomiting, shivering or pruritis) were evaluated. RESULTS: Baseline demographic variables were similar in the 2 groups (p-value＞0.05). Neonatal outcomes were also similar in both the groups. The time to achieve sensory block to T10 (3.2 ± 1.5 vs 2.5 ± 1.3 minutes) or to the maximal level (9.8 ± 3.1 vs 7.9 ± 2.3 minutes) was longer in the ropivacaine group (p-value 0.048) but the median maximal level of sensory block was similar between the two groups (p-value＞0.05). Duration of sensory block was shorter in the ropivacaine group (160.5± 22.2 vs 182.3± 30.5 minutes) (p-value 0.03). Duration of motor block was also significantly shorter than bupivacaine group (112.5 ± 45 vs 165.3 ± 26) (p-value 0.004). CONCLUSION: Spinal anesthesia for elective cesarean delivery with intrathecal 24 mg of 0.75% isobaric ropivacaine provided clinically effective surgical anesthesia of shorter duration without compromising neonatal outcome and can be used as an effective and safe alternative to bupivacaine.
延伸閱讀
- Wong, J. O. N., Tan, T. D. M., Leung, P. O., Tseng, K. F., & Cheu, N. W. (2003). Spinal Anesthesia with Two Different Dosages of 0.75% Glucose-free Ropivacaine: A Comparison of Efficacy and Safety in Chinese Parturients Undergoing Cesarean Section. Acta Anaesthesiologica Sinica, 41(3), 131-138. https://doi.org/10.6955/AAS.200309.0131
- Wang, S. C., Chang, Y. Y., Chang, K. Y., Hu, J. S., Chan, K. H., & Tsou, M. Y. (2008). Comparison of Three Different Concentrations of Ropivacaine for Postoperative Patient-controlled Thoracic Epidural Analgesia after Upper Abdominal Surgery. Acta Anaesthesiologica Taiwanica, 46(3), 100-105. https://www.airitilibrary.com/Article/Detail?DocID=02541319-200809-46-3-100-105-a
- Powell, M. F., Jarzombek, K. W., Venhuizen, K. J., Tubinis, M. D., Morgan, C. J., & Frölich, M. A. (2019). Comparing Bupivacaine, Lidocaine, and a Combination of Bupivacaine and Lidocaine for Labor Epidural Activation: A Prospective, Randomized, Double-Blind Study. Asian Journal of Anesthesiology, 57(2), 55-60. https://doi.org/10.6859/aja.201906_57(2).0004
- Powell, M. F., Jarzombek, K. W., Venhuizen, K. J., Tubinis, M. D., Morgan, C. J., & Frölich, M. A. (2019). Comparing Bupivacaine, Lidocaine, and a Combination of Bupivacaine and Lidocaine for Labor Epidural Activation: A Prospective, Randomized, Double-Blind Study. Asian Journal of Anesthesiology, (), 1-6. https://doi.org/10.6859/aja.201908/PP.0004
- Chu, C. C., Shu, S. S., Lin, S. M., Chu, N. W., Leu, Y. K., Tsai, S. K., & Lee, T. Y. (1995). The Effect of Intrathecal Bupivacaine with Combined Fentanyl in Cesarean Section. Acta Anaesthesiologica Sinica, 33(3), 149-154. https://www.airitilibrary.com/Article/Detail?DocID=P20170519003-199509-201904180016-201904180016-149-154